HLA I shield tumor skin T lymphocytes from NK-cell-mediated elimination

被引：0
|
作者：
Chang, Y. [1 ]
Ziegler, M. [1 ]
Ignatova, D. [1 ]
Ivanov, P. [2 ]
Profanter, R. [2 ]
Kerl, K. [1 ]
Dummer, R. [1 ]
Contassot, E. [1 ]
French, L. E. [1 ]
Cozzio, A. [3 ]
Misailovic, S. [4 ]
Hoetzenecker, W. [5 ]
Vechev, M. [2 ]
Guenova, E. [6 ]
机构：
[1] USZ, Dermatol, Zurich, Switzerland
[2] ETH, Comp Sci, Zurich, Switzerland
[3] KSSG, Dermatol, St Gallen, Switzerland
[4] Univ Illinois, Comp Sci, Champaign, IL 61820 USA
[5] Kepleruniklinikum, Dermatol, Linz, Austria
[6] USZ, KSSG, Dermatol, Zurich, Switzerland
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2018年 / 138卷 / 05期
关键词：
D O I：
10.1016/j.jid.2018.03.1044
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
1032
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [41] HLA class I-restricted and tumor-specific cytotoxic T lymphocytes from metastatic lymph nodes of esophageal cancers
    Toh, U
    Yamana, H
    Nakao, M
    Imai, Y
    Seki, N
    Takasu, H
    Kaneshige, T
    Fujita, H
    Shirouzu, K
    Itoh, K
    CELLULAR IMMUNOLOGY, 1997, 177 (02) : 137 - 143
  • [42] T-cell help in the tumor microenvironment enhances rituximab-mediated NK-cell ADCC
    Arora, Jyoti
    Ayyappan, Sabarish
    Yin, Chaobo
    Smith, Brian J.
    Lemke-Miltner, Caitlin D.
    Wang, Zhaoming
    Farooq, Umar
    Weiner, George J.
    BLOOD, 2024, 143 (18) : 1816 - 1824
  • [43] Study of HLA class I restriction and the directed antigens of cytotoxic T lymphocytes at the tumor sites of ovarian cancer
    Yamada, A
    Kawano, K
    Harashima, N
    Niiya, F
    Nagai, K
    Kobayashi, T
    Mine, T
    Ushijima, K
    Nishida, T
    Itoh, K
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999, 48 (2-3) : 147 - 152
  • [44] Study of HLA class I restriction and the directed antigens of cytotoxic T lymphocytes at the tumor sites of ovarian cancer
    Akira Yamada
    Koichiro Kawano
    Nanae Harashima
    Fumihiko Niiya
    Kouji Nagai
    Terutada Kobayashi
    Takashi Mine
    Kimio Ushijima
    Takashi Nishida
    Kyogo Itoh
    Cancer Immunology, Immunotherapy, 1999, 48 : 147 - 152
  • [45] Destructive impact of t-lymphocytes, NK and mast cells on basal cell layers: implications for tumor invasion
    Hongyan Yuan
    Yi-Hsuan Hsiao
    Yiyu Zhang
    Jinlian Wang
    Chao Yin
    Rong Shen
    Yiping Su
    BMC Cancer, 13
  • [46] Destructive impact of t-lymphocytes, NK and mast cells on basal cell layers: implications for tumor invasion
    Yuan, Hongyan
    Hsiao, Yi-Hsuan
    Zhang, Yiyu
    Wang, Jinlian
    Yin, Chao
    Shen, Rong
    Su, Yiping
    BMC CANCER, 2013, 13
  • [47] HLA class-I-specific inhibitory receptor in human T lymphocytes: Interference with T-cell functions
    Mingari, MC
    Ponte, M
    Vitale, C
    Schiavetti, F
    Bellomo, R
    Bertone, S
    Nanni, L
    RESEARCH IN IMMUNOLOGY, 1997, 148 (03): : 150 - 155
  • [48] MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal
    Menier, C
    Riteau, B
    Carosella, ED
    Rouas-Freiss, N
    INTERNATIONAL JOURNAL OF CANCER, 2002, 100 (01) : 63 - 70
  • [49] The mica triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal
    Menier, C
    Riteau, B
    Bruel, S
    Carosella, E
    Rouas-Freiss, N
    TISSUE ANTIGENS, 2002, 59 : 4 - 4
  • [50] Synergy of combined immune checkpoint modulation and CD30/CD16A-TandAb-induced NK-cell-mediated target cell lysis enhances tumor eradication in vivo
    Zhao, X.
    Rajasekaran, N.
    Reusch, U.
    Marschner, J. P.
    Treder, M.
    Kohrt, H.
    EUROPEAN JOURNAL OF CANCER, 2016, 55 : S20 - S20
12345